Royalty Report: Medical, Device, Cancer – Collection: 2011

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 11

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 11

Primary Industries

  • Medical
  • Device
  • Cancer
  • Therapeutic
  • Diagnostic
  • cardiac
  • Technical Know How
  • Pain
  • Surgical
  • Coating

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 2011

License Grant
Licensor hereby grants, and Licensee hereby accepts, upon the terms and conditions set forth in this Agreement, (i) a worldwide exclusive license under the Patent Rights a Microwave Applicator/Receiver Apparatus (U.S. Patent No. 4,583,556).
License Property
Licensed Products means a microwave generator and display and a disposable catheter containing a microwave antenna used for ablation/heating of myocardial tissue (hereinafter referred to as a 'Catheter' or 'Catheters') with a thermocouple based temperature sensing device (or any other temperature sensing device acceptable to Licensee) with logic and feedback circuitry coupled to the generator.  For use in medical treatment of living tissue a microwave applicator/receiver device capable of applying microwave-frequency radiant energy to living tissue by way of insertion thereof through an opening into the body and of receiving similar energy radiating from within such tissue while in contact with said tissue, said device comprising an inner electrical conductor and an outer electrical conductor substantially shielding said inner conductor in a non-resonant transmission line configuration capable of propagating microwave energy in a frequency band suitable for heating living tissue, said inner conductor having an unshielded portion extending a distance beyond said outer conductor, and a helical coil surrounding said extending portion of said inner conductor and including first and second means connected between the ends of said outer and inner conductors respectively, for providing a traveling wave pattern of microwave radiation into tissue which pattern is characterized by substantially uniform intensity distribution over a prescribed spatial distribution within said tissue thus providing uniform heating absent hot-spots over the length of said helical coil, said first means providing a conductive connection from the outer conductor to the helical coil, said second means comprising a substantially radial conductor interconnecting the helical coil with the inner conductor extending portion with an absence of any conductor extending axially substantially beyond said helical coil, said helical coil having multiple wire turns each separated from the next by an inter-turn spacing greater than the diameter of the helical conductor wire, the axial length of said helical coil being substantially greater than the diameter of the helical coil, and including a substantially smooth dielectric sleeve covering at least said helical coil.

IPSCIO Record ID: 2846

License Grant
The Licensor granted the Licensee the exclusive license to make, have made, use, sell, and put into use Licensed Products under U.S. Patent No. 4,583,556, for a Microwave Applicator/Receiver Apparatus and Japanese Patent No. 1426077.
License Property
Licensed Products means a microwave generator/receiver/diplexer device, including a disposable catheter, containing a microwave antenna used for ablation/heating of myocardial tissue.

IPSCIO Record ID: 1495

License Grant
The Licensor granted a non-exclusive, non-transferable license of certain rights to one of the Licensee's U.S. Patent number 4,967,765 for heating the prostate with microwave energy; applicators for insertion into the urethra and the related microwave treatment systems which are covered by the Licensed Patent.
License Property
The term 'Licensed Products' shall mean applicators for insertion into the urethra and the related microwave treatment systems, which are covered by the Licensed Patent including the EDAP Prostatron systems and associated parts, accessories, and applicators.

The term 'Licensed Patent' shall mean U.S. Patent No. 4,967,765 .

IPSCIO Record ID: 299258

License Grant
This agreement is to compromise, resolve and settle all asserted and unasserted claims relating to the allegations, and license technology.

Licensor grants an irrevocable, non-exclusive, worldwide right and license under the Licensed Patents only within the Technology Field to undertake Product Related Activities for Licensed Products and develop, make, have made, market, use, authorize others to use, import, distribute, sell, have sold and offer to sell Licensed Products, for the life of the Licensed Patents.

License Property
The patents are for Urethral inserted applicator for prostate hyperthermia and therapeutic prostatic thermotherapy.

Licensed Products shall mean Licensees Current Products and Reasonable Modifications thereof developed, manufactured, used, marketed, offered for sale, sold, imported, licensed or distributed by or on behalf of a Licensee Party or a permitted successor or assign under this Agreement, directly or through their respective manufacturers, distributors, contractors, resellers, and other intermediaries.

Current Products of a Party shall mean products and components thereof commercially available from that Party or its Affiliates at or before the Effective Date in the Technology Field, which for Licensee is the Prolieve Thermodilation System and for Licensor is the TherMatrx System.

Prolieve Thermodilation System offers a unique “Thermodilatation” treatment for symptoms of enlarged prostate, also known as benign prostatic hyperplasia (BPH). Prolieve® is a combination therapy simultaneously using Focused Microwave Heating together with Pressurized Balloon Dilatation therapy.

Field of Use
Licensee is, in part, in the business of developing, making, marketing and selling products, therapies and technologies that use heat generated by microwave energy to treat benign prostatic hyperplasia, including a product currently sold under the brand Prolieve Thermodilation System®.

Technology Field shall mean the field of microwave therapy for treating benign prostatic hyperplasia (BPH) and prostatitis.

IPSCIO Record ID: 88532

License Grant
The Licensor hereby grants to the Licensee, and the Swiss Licensee hereby accepts, a non-exclusive, royalty-bearing right and license under the Licensed IP to use, make, have made, sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use; provided, however, that upon the occurrence of a License Conversion Event, the portion of the non-exclusive license consisting of the non-exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (the Non-Exclusive Distribution License) shall immediately, and without the need for any action on the part of either party, convert into an exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (Exclusive Distribution License); provided, however, that the exclusivity of such Exclusive Distribution License shall be subject to, and shall not impact, any license rights previously granted in favor of Greatbatch pursuant to the Greatbatch License Agreement; provided, further, however, that if the Licensee fails to obtain FDA Approval for the Licensed Products within six (6) years after the License Conversion Date, the Exclusive Distribution License shall become convertible by the Licensor, at its sole discretion, back into a Non-Exclusive Distribution License. For the avoidance of doubt, during the Term, the non-exclusive, royalty-bearing license to use, make and have made Licensed Products in the Territory during the Term for applications within the Field of Use shall continuously remain a non-exclusive license.  License Conversion Event means the first to occur of (i) receipt of a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for application within the Field of Use; (ii) receipt of FDA Approval or (iii) completion by the Licensee of a human clinical study demonstrating safety and efficacy required to obtain (A) a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for applications within the Field of Use, or (B) FDA Approval.
License Property
United States (U.S.) Licensed Patents
8,954,148  Key Fob controller for an implantable neurostimulator  
8,483,836  Automated search to identify a location for electrical stimulation to treat a patient
8,515,545  Current steering neurostimulator device with unidirectional current sources
8,571,667  Active current control using the enclosure of an implanted pulse generator
8,738,153  Implantable lead with braided conductors
8,757,485  System and method for using clinician programmer and clinician programming data for inventory and manufacturing prediction and control
8,761,892  Active current control using the enclosure of an implanted pulse generator
8,761,897  Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer
8,781,592  Identifying an area for electrical stimulation to treat a patient
8,812,125  Systems and methods for the identification and association of medical devices
8,868,199  System and method of compressing medical maps for pulse generator or database storage
8,874,219  Arbitrary waveform generator and neural stimulation application
8,903,496  Clinician programming system and method
8,983,616  Method and system for associating patient records with pulse generators
8,996,115  Charge balancing for arbitrary waveform generator and neural stimulation application
8,996,117  Arbitrary waveform generator and neural stimulation application with scalable waveform feature
8,700,175  Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,002,466  Diversity antennas for neurostimulator programming devices
9,031,664  Current steering neurostimulator device with unidirectional current sources
9,031,666  Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,067,074  Automated search to identify a location for electrical stimulation to treat a patient
9,072,903  System and method of establishing a protocol for providing electrical stimulation with a stimulation system to treat a patient
9,098,610  Communication for implantable medical devices
9,101,767  Measuring load impedance with active stimulation pulses in an mplanted pulse generator
9,126,043  Patient handheld device for use with a spinal cord stimulation system
D663,035  Two-port implantable medical device
D665,086  Three-port implantable medical device
D665,087  Multi-port implantable medical device
D671,900  Pocket controller for implantable neurostimulator
D698,779  Clinician programmer for implantable neurostimulator
Field of Use
Field of Use means deep brain stimulation for movement disorders (i.e. Parkinson’s disease and/or essential tremor).

IPSCIO Record ID: 5639

License Grant
The Licensor granted the Licensee an exclusive, worldwide, royalty-bearing, limited license under the Licensed Technology to make, have made, import, use, sell and have sold the Devices solely within the Field of Use.
License Property
The Licensor’s technology allows the user to direct microwave energy emitted at the end of a catheter in a specific direction, which is believed to be a distinct advantage in the possible treatment of prostate disease.

09/248,165     A medical instrument for providing/withdrawing heat from a target
09/248,168    A medical instrument having a collinear      
09/248,170    Relates to a unique antenna structure        
09/377,458    Heat Pipe Array  An array of antennas for providing increased uniformity of radiated microwave energy into a tissue mass
6,181,970        Microwave devices used in medical hyperthermia and thermotherapy

Field of Use
Field of Use shall mean the treatment of (a) benign prostatic hyperplasia; (b) prostatitis; (c) prostate cancer; or (d) any other conditions of urologic disorder which may be diagnosed, imaged or treated using a catheter-based microwave technology or sensor imaging systems.  Technology, know-how, and patents related to urologic disorders that may be detected or treated using a catheter-based microwave technology.

IPSCIO Record ID: 245918

License Grant
License Grant to Licensee under the Licensor Infusion Claims. Subject to the terms and conditions of this Agreement, including, without limitation, the limitations set forth in this agreement, and in consideration of the payment of royalties by Licensee to Licensor, Licensor hereby grants to Licensee and Licensee’s Affiliates, under the Licensor Infusion Claims, a non-exclusive license throughout the Licensed Territories in the Field to make, have made, use, practice, import, offer to sell, sell and otherwise dispose of or make available for use, directly or indirectly, Products and Methods which, but for the license granted herein, would infringe any one or more of the Licensor Infusion Claims. Notwithstanding any other provision of this Agreement
(a) the foregoing license extends only to such Products and Methods as are offered for sale, sold and otherwise disposed of or made available for use under Licensee’s (or its Affiliates’) own trademarks, tradenames and/or label(s), which shall be the most prominent trademarks, tradenames and/or label(s) thereon, and does not extend, and shall not be construed to extend, to any Products, or parts or components thereof, offered for sale, sold or otherwise disposed of or made available for use to any Third Person by Licensee or its Affiliates for resale or re-distribution by such Third Person solely under such Third Person’s own trademarks, tradenames and/or label(s); and
(b) Licensee, on behalf of itself and its Affiliates, hereby covenants and agrees not to market, offer for sale or sell any Products or Methods that, absent the foregoing license, would infringe the Licensor Infusion Claims, until eighteen (18) months after the Effective Date.
License Property
Licensor Infusion Claims shall mean those Claims of any patents within the Licensor Patent Portfolio which require for infringement liquid infusion capability or the use of liquid infusion.

Licensor Patent Portfolio
U.S. Patent No. 5,458,597 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,472,441 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,486,161 – Medical probe device and method

Field of Use
Field shall mean Products and Methods used to ablate tumors with radio frequency (RF) electrical energy.  Sub-Field shall mean tumor ablation within the Field directed to specific organs or regions of the body.

IPSCIO Record ID: 376750

License Grant
Licensee has an exclusive license to reproduce, distribute, sell, lease, display and perform and otherwise use the Property (including the SOLACE medical device) for use in pain management.
License Property
Licensed intellectual property consists of several issued and pending US patents licensed.
Licensed patent consists of the following
– US Patent 7,967,839 Electromagnetic Treatment of Tissues and Cells
– US Patent 10,271,900 Inductive Heating of Tissues Using Alternating Magnetic Fields and Uses Thereof
– US Patent 10,441,346 Inductive Heating of Tissues Using Alternating Magnetic Fields and Uses Thereof

SOLACE, a non-invasive medical device that uses electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The SOLACE platform is based on proprietary high-frequency magnetic induction technology, which is referred to as Electromagnetic Induction (“EMI”). Magnetic fields are induced beneath the skin surface to create localized, planar heat in the dermis and deeper muscle, while selectively avoiding sensitive structures in the epidermis and fat layers. By comparison, the SOLACE device creates currents in discreet planes beneath the tissue surface rather than directing energy through the planes and penetrating the epidermis. Therefore, the EMI technology may provide for shorter duration of treatments and a more comfortable patient experience vs. other energy-based technologies. The SOLACE device utilizes a directional handpiece to apply the planar heat more precisely to discrete areas of the body, which may provide clinicians with greater therapeutic control.

Field of Use
SOLACE is a non-invasive medical device that uses electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 669

License Grant
Licensor hereby grants Licensee its Affiliates an exclusive, worldwide, sublicensable license in and to Licensor’s IP to (i) use, make, have made, sell, offer to sell, import, modify, distribute, perform and otherwise exploit the Exclusive Products and (ii) enforce such Licensor’s IP against other Persons and collect past, present and future damages from any other Person’s infringement or misappropriation of Licensor’s IP but all of the foregoing rights and licenses are limited to the Field.
License Property
“Non-Drug Coated” means devices not coated with a drug or a drug eluting polymer coating.  Exclusive Product/Services  Vascular stents including coronary, neuro or peripheral applications of coated or uncoated stents; Embolic protection devices, aneurysm coils and all other vascular implants (other than stents); RF ablation probes and ablation fluid.

Non-Exclusive Product/Services Biopsy needles, including aspiration, cutting needles and breast localization needles; Interventional guidewires (for use in all applications); Interventional vascular catheters (<6 hours), including PTCA, predilation, etc.; Indwelling vascular catheters (>6 hours), including CVC, PICC, etc.; Pacemakers, including leads; Implantable cardiac defibrillators and related devices, including their leads; Auditory implants, e.g. cochlear implants; Neuro stimulation including deep brain.

Field of Use
“Field” means systems, devices, components, compositions and processes for magnetic resonance imaging, including without limitation for providing or enhancing (a) safety, effectiveness, image quality and/or image compatibility or (b) the visualization of medical devices in vivo.

IPSCIO Record ID: 257491

License Grant
The parties desire to amend and restate the relationship between the parties that currently exists by virtue of the Exclusive License Agreement dated  January 30, 1973,  to restate the grant to assigned Licensee of the sole and exclusive worldwide license for the use of said patents, patent applications, and inventions.

Licensor grants the sole and exclusive license and right to manufacture, use, sell, rent and lease or otherwise dispose of any and all devices under the Patent Rights and or any Improvements thereof throughout the United States, its territories and possessions, and in any and all foreign countries, subject to the terms and conditions set forth in this Exclusive License Agreement.

License Property
The licensed property includes Implantable Defibrillators, lead devices and other device for use with an Implantable Defibrillator.

Defibrillation is a treatment for life-threatening cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT). A defibrillator delivers a dose of electric current (often called a countershock) to the heart.

Field of Use
The field of use is Implantable Defibrillators.  This agreement pertains to the medical industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.